Review Supports Testosterone for Low Sexual Desire in Women
FRIDAY, July 26, 2019 -- For postmenopausal women with low sexual desire causing distress, testosterone is an effective treatment, with a preference for nonoral administration, according to a re
FDA Approves Baqsimi
FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia
July 24, 2019 -- The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergenc
FDA Approves Ruxience
FDA Approves Ruxience (rituximab-pvvr), a Biosimilar to Rituxan
July 23, 2019 - Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) has approved Ruxience (rituximab-pvvr), a biosimilar to Ritux
Hey! Thats the Wrong Knee, Doctor
THURSDAY, July 18, 2019 -- Say you go in for knee surgery and find the surgeon operated on the wrong leg. Or you received a drug you know youre allergic to.
It happens. In fact, about 1 in 20 patients is a victim of p
FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
SUMMIT, N.J.--(BUSINESS WIRE) July 19, 2019 -- Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (ap
FDA Approves Recarbrio
FDA Approves Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
KENILWORTH, N.J.--(BUSINESS WIRE)-- July 17, 2019 Merck (NYSE:MRK)